- Report
- October 2024
- 191 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- April 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2024
- 450 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- March 2022
- 100 Pages
Global
From €5229EUR$5,500USD£4,393GBP
- Report
- March 2020
- 96 Pages
Global
From €1854EUR$1,950USD£1,557GBP
- Book
- December 2020
- 416 Pages

Nanopharmaceuticals are a type of pharmaceutical drug that utilizes nanotechnology to improve drug delivery and efficacy. These drugs are designed to target specific cells or tissues, allowing for more precise and effective treatments. Nanopharmaceuticals are also able to reduce the amount of drug needed to achieve the desired effect, reducing the risk of side effects.
Nanopharmaceuticals are increasingly being used in the pharmaceutical industry, as they offer a number of advantages over traditional drugs. These include improved bioavailability, increased solubility, and improved stability. Additionally, nanopharmaceuticals can be used to deliver drugs to specific areas of the body, allowing for more targeted treatments.
Some of the companies in the nanopharmaceutical market include AbbVie, AstraZeneca, Merck, Novartis, Pfizer, and Roche. Show Less Read more